Liu, C., Yang, W., Chien, C., Wu, C., Chuang, J., Chen, P., . . . Chang, K. (2024). CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity. Cell Death & Disease, 15(6), . https://doi.org/10.1038/s41419-024-06784-6
Chicago-referens (17:e uppl.)Liu, Chan-Chuan, et al. "CXCR7 Activation Evokes the Anti-PD-L1 Antibody Against Glioblastoma by Remodeling CXCL12-mediated Immunity." Cell Death & Disease 15, no. 6 (2024). https://doi.org/10.1038/s41419-024-06784-6.
MLA-referens (9:e uppl.)Liu, Chan-Chuan, et al. "CXCR7 Activation Evokes the Anti-PD-L1 Antibody Against Glioblastoma by Remodeling CXCL12-mediated Immunity." Cell Death & Disease, vol. 15, no. 6, 2024, https://doi.org/10.1038/s41419-024-06784-6.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.
